Skip to content
10-Q

Quarterly Report

OnKure Therapeutics, Inc. OKUR

0001193125-25-178981

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 13.51M sh
Shares Diluted Q2 2025 · Jun 30, 2025 13.47M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 315.48K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 314.75K sh
Capex Q2 2025 · Jun 30, 2025 $31K
Capex restated Q2 2025 · Jun 30, 2024 $19K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$27.28M
Operating Cash Flow restated Q2 2025 · Jun 30, 2024 −$17.1M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $83.37M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $110.76M
Stockholders Equity Q2 2025 · Jun 30, 2025 $78.17M
Stockholders Equity Q2 2025 · Mar 31, 2025 $90.65M
Stockholders Equity Q2 2025 · Dec 31, 2024 $103.83M
Stockholders Equity Q2 2025 · Sep 30, 2024 −$135.05M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 −$123.58M
Stockholders Equity restated Q2 2025 · Mar 31, 2024 −$111.26M
Stockholders Equity restated Q2 2025 · Dec 31, 2023 −$101.84M
Current Liabilities Q2 2025 · Jun 30, 2025 $7.6M
Current Liabilities Q2 2025 · Dec 31, 2024 $10.53M
Total Liabilities Q2 2025 · Jun 30, 2025 $7.9M
Total Liabilities Q2 2025 · Dec 31, 2024 $11.08M
Current Assets Q2 2025 · Jun 30, 2025 $84.55M
Current Assets Q2 2025 · Dec 31, 2024 $113M
Total Assets Q2 2025 · Jun 30, 2025 $86.07M
Total Assets Q2 2025 · Dec 31, 2024 $114.91M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.14
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.33
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$44.82
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$75.22
Eps Basic Q2 2025 · Jun 30, 2025 −$1.14
Eps Basic Q2 2025 · Jun 30, 2025 −$2.33
Eps Basic restated Q2 2025 · Jun 30, 2024 −$44.82
Eps Basic restated Q2 2025 · Jun 30, 2024 −$75.22
Sga Expense Q2 2025 · Jun 30, 2025 $3.71M
Sga Expense Q2 2025 · Jun 30, 2025 $7.7M
Sga Expense restated Q2 2025 · Jun 30, 2024 $3.59M
Sga Expense restated Q2 2025 · Jun 30, 2024 $4.86M
Rd Expense Q2 2025 · Jun 30, 2025 $12.61M
Rd Expense Q2 2025 · Jun 30, 2025 $25.63M
Rd Expense restated Q2 2025 · Jun 30, 2024 $10.75M
Rd Expense restated Q2 2025 · Jun 30, 2024 $19.32M
Net Income Q2 2025 · Jun 30, 2025 −$15.39M
Net Income Q2 2025 · Jun 30, 2025 −$31.32M
Net Income Q2 2025 · Mar 31, 2025 −$15.93M
Net Income Q2 2025 · Dec 31, 2024 −$17.44M
Net Income Q2 2025 · Sep 30, 2024 −$11.56M
Net Income restated Q2 2025 · Jun 30, 2024 −$14.14M
Net Income restated Q2 2025 · Jun 30, 2024 −$23.68M
Net Income restated Q2 2025 · Mar 31, 2024 −$9.54M
Operating Income Q2 2025 · Jun 30, 2025 −$16.32M
Operating Income Q2 2025 · Jun 30, 2025 −$33.32M
Operating Income restated Q2 2025 · Jun 30, 2024 −$14.34M
Operating Income restated Q2 2025 · Jun 30, 2024 −$24.18M